According to the Mounjaro Prescribing Information, these include nausea (17-22%), diarrhea (13-17%), decreased appetite (10-14%), vomiting (6-10%), constipation (5-7%), and dyspepsia (5-7%)
If you, or someone you care for, is taking GLP-1s and you notice symptoms such as severe, persistent stomach pain that may radiate to the back and may be accompanied by nausea and vomiting, then we advise you speak to a healthcare professional and report it via our yellow card scheme. Separately, the MHRA said that patients taking GLP-1s had been recruited to the Yellow Card Biobank study, a collaboration between the MHRA and Genomics England, which will investigate whether the risk of an inflamed pancreas can be influenced by an individuals genes
Still, you have options even if you find yourself traveling
These hormones work together to help lower blood sugar levels by increasing insulin production and slowing the release of glucose from the liver